Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

University of Glasgow: Glasgow, GB

(Clinical Research Garscube)
Employment
Source: check_circle
University of Glasgow

Works (26)

Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma

Molecular Cancer Therapeutics
2024-03-04 | Journal article
DOI: 10.1158/1535-7163.MCT-23-0460
Contributors: Cha Len Lee; Grainne M. O'Kane; Warren P. Mason; Wen-Jiang Zhang; Pavlina Spiliopoulou; Aaron R. Hansen; Robert C. Grant; Jennifer J. Knox; Tracy L. Stockley; Gelareh Zadeh et al.
Source: check_circle
Crossref

Promising and Minimally Invasive Biomarkers: Targeting Melanoma

Cells
2023-12-20 | Journal article
DOI: 10.3390/cells13010019
Contributors: Pavlina Spiliopoulou; Carlos Diego Holanda Lopes; Anna Spreafico
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma

British Journal of Cancer
2023-05-11 | Journal article
DOI: 10.1038/s41416-023-02166-5
Contributors: Abhenil Mittal; Esmail Al-Ezzi; Xuan Li; Brian Moloney; Brooke Wilson; Pavlina Spiliopoulou; Srikala Sridhar; Nazanin Fallah-Rad; Peter Chung; Robert James Hamilton et al.
Source: check_circle
Crossref

Data from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6543402
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Data from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6543402.v1
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Data from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522515
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Data from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522515.v1
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Data from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522512
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Data from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522512.v1
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Figure from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522506
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Figure from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522506.v1
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Table from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522503
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Table from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522503.v1
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Table from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522500
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Table from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522500.v1
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Table from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522497
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Table from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522494.v1
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Table from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522494
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Supplementary Table from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522497.v1
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy

Cell Death & Disease
2023-01-20 | Journal article
DOI: 10.1038/s41419-022-05548-4
Contributors: Pavlina Spiliopoulou; Helena J. Janse van Rensburg; Lisa Avery; Vathany Kulasingam; Albiruni Razak; Philippe Bedard; Aaron Hansen; Andrzej Chruscinski; Ben Wang; Maria Kulikova et al.
Source: check_circle
Crossref

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers

International Journal of Molecular Sciences
2023-01-09 | Journal article
DOI: 10.3390/ijms24021294
Contributors: Pavlina Spiliopoulou; Olga Vornicova; Sofia Genta; Anna Spreafico
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy

2022-11-11 | Preprint
DOI: 10.21203/rs.3.rs-2214679/v1
Contributors: Pavlina Spiliopoulou; Helena Janse van Rensburg; Lisa Avery; Vathany  Kulasingam; Albiruni Razak; Philippe Bedard; Aaron Hansen; Andrzej Chruscinski; Ben Wang; Maria Kulikova et al.
Source: check_circle
Crossref

Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma

Molecular Cancer Therapeutics
2022-04-01 | Journal article
DOI: 10.1158/1535-7163.MCT-21-0743
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Nayana Iyer; Sophie McNamara et al.
Source: check_circle
Crossref

Metronomic oral cyclophosphamide in relapsed ovarian cancer

International Journal of Gynecological Cancer
2021-07 | Journal article
DOI: 10.1136/ijgc-2021-002467
Contributors: Pavlina Spiliopoulou; Samantha Hinsley; Iain A McNeish; Patricia Roxburgh; Ros Glasspool
Source: check_circle
Crossref

Dual G9A and EZH2 inhibition stimulates an anti-tumour immune response in ovarian high-grade serous carcinoma

2021-05-11 | Other
DOI: 10.1101/2021.05.09.443282
Contributors: Pavlina Spiliopoulou; Sarah Spear; Hasan Mirza; Ian Garner; Lynn McGarry; Fabio Grundland-Freile; Zhao Cheng; Darren P. Ennis; Sophie McNamara; Marina Natoli et al.
Source: check_circle
Crossref

A Case of Lenvatinib-Induced Focal Segmental Glomerulosclerosis (FSGS) in Metastatic Medullary Thyroid Cancer

Case Reports in Oncological Medicine
2018-10-03 | Journal article
DOI: 10.1155/2018/6927639
Contributors: Kathryn Fleming; James McGuinness; David Kipgen; Hilary Glen; Pavlina Spiliopoulou
Source: check_circle
Crossref

Peer review (4 reviews for 1 publication/grant)

Review activity for British journal of cancer. (4)
How many people are using ORCID?